• October 20, 2016

    Ex-Sports Media Exec Pleads Out In FIFA Corruption Case

    A former Miami-based sports marketing executive Thursday admitted to arranging for millions of dollars in bribes for former FIFA Vice President Jeffrey Webb in exchange for lucrative media rights to soccer matches.

  • October 20, 2016

    GSK, Teva Urge High Court To Review Pay-For-Delay Accords

    GlaxoSmithKline and Teva urged the U.S. Supreme Court on Wednesday to review their challenge of a Third Circuit decision allowing a pay-for-delay case over the seizure drug Lamictal to move forward, saying the U.S. Solicitor General’s recent recommendation that the high court deny review was flawed.

  • October 20, 2016

    FCC’s Pai Slams Agency's Overreach Amid Court Reversals

    Courts have appropriately taken action against Federal Communications Commission overstepping, Republican Commissioner Ajit Pai said Thursday, but the agency continues a wrongheaded focus on accomplishing policy objectives without regard for legal authority.

  • October 20, 2016

    Justices Could Revisit Conspiracy Standard In ATM Fee Fight

    The U.S. Supreme Court this term will consider whether ATM fee rules amount to a price-fixing conspiracy by credit card companies and big banks in a case that could provide an opportunity for the justices to clarify the standard plaintiffs must overcome to allege an antitrust conspiracy.

  • October 20, 2016

    'Hasty' Judge Botched RBS Libor Claim Again, 2nd Circ. Told

    Hotel developer Budget Portfolio Properties LLC urged the Second Circuit Thursday to again reverse a Manhattan trial judge who twice has dismissed its claims that Royal Bank of Scotland's rate-rigging drove it into bankruptcy in Texas, leaving a three-judge panel with questions about which federal circuit law to apply.

  • October 20, 2016

    FTC, Antitrust Org Ask 3rd Circ. To Rethink Doryx Decision

    The Federal Trade Commission and American Antitrust Institute on Wednesday each asked the Third Circuit to rethink its dismissal of Mylan Pharmaceuticals Inc.'s product-hopping suit against Warner Chilcott Ltd. over the acne medication Doryx, arguing the court changed the Sherman Act’s standard of harm and misinterpreted an array of precedent. 

  • October 20, 2016

    Top EU Court Urged To Revive Intel's Appeal Of €1B Fine

    An adviser to Europe's top court on Thursday said Intel Corp. should get another chance to fight a €1.1 billion ($1.5 billion) antitrust fine over its exclusive loyalty rebates, urging the high court to set aside a judgment upholding the fine.

  • October 20, 2016

    Currency Buyers Say Libor-Rigging Suit Has Legs

    A putative class of foreign currency buyers urged a New York federal court Wednesday not to dismiss their antitrust suit alleging several of the world’s largest banks forced them to pay artificially high prices for euro-dollar trades, saying that as direct buyers they were directly harmed by a price-fixing conspiracy.

  • October 20, 2016

    2nd Circ. Affirms Ex-NY State Senator's Graft Conviction

    The Second Circuit affirmed the corruption convictions of former Democratic State Sen. Malcolm A. Smith and former Queens Republican politico Vincent A. Tabone on Thursday, finding that the election bribery scheme for which a jury found them guilty was properly charged under the federal honest services wire fraud statute.

  • October 20, 2016

    Walgreens, Rite Aid Delay Closing Of $17B Merger

    Drugstore giant Walgreens on Thursday delayed the closing of its planned $17.2 billion merger with Rite Aid by about three months, giving the companies more time to secure regulatory approval for the transaction.

  • October 20, 2016

    Aluminum Ruling No Help For Shell, Crude Traders Say

    Derivatives traders accusing two Royal Dutch Shell PLC affiliates of manipulating the price of crude oil and crude oil futures told a New York federal judge on Wednesday that a recent ruling dismissing aluminum market manipulation claims has no effect on their case.

  • October 20, 2016

    Proposed Verizon-XO Deal Risks Consumer Harm, FCC Told

    Trade group Incompas has again pressed the Federal Communications Commission to deny Verizon’s proposed $1.8 billion purchase of XO Holdings’ fiber-optic network business, arguing that Verizon has no use for XO's services and is only pursuing the deal to eliminate XO as a competitor.

  • October 20, 2016

    Aetna-Humana Row Survives ACA Exchange Exits, DOJ Says

    With trial nearing, competition officials urged a D.C. federal judge on Thursday not to toss allegations the Aetna-Humana merger would stifle competition in Affordable Care Act markets after the companies pulled out of several exchanges, likening such dismissal to closing the blinds on an otherwise functioning factory.

  • October 20, 2016

    Top Nassau County, NY, Official Indicted In Bribery Scheme

    The top elected official for Nassau County, New York, was indicted on Thursday on federal corruption charges, accused of taking expensive gifts and trips — along with a no-show job for his wife — in exchange for arranging a town to guarantee private loans to a restaurateur and assigning him county food service contracts, according to court filings.

  • October 19, 2016

    Pension Co., Bank Escape Tribe’s Embezzlement Suit

    A California federal judge on Wednesday tossed claims asserted against a bank, a pension company and a financial adviser in a massive lawsuit by the Paskenta Band of Nomlaki Indians accusing former tribal officials of a wide-reaching embezzlement scheme.

  • October 19, 2016

    Dow Derivative Suit Fails To Show Board's Bad Faith: Judge

    A Michigan federal judge on Wednesday tossed a derivative investor suit alleging Dow Chemical Co.’s top brass failed to act against a price-fixing scheme that resulted in an $835 million class settlement, saying the company wasn’t necessarily wrong to refuse an investor’s litigation demand.

  • October 19, 2016

    Sprint Says It's Waited Long Enough For Biz Data Reform

    Sprint chief Marcelo Claure has pressed the Federal Communications Commission's Democratic majority to move forward with a revised proposal to promote competition and regulate rates in the market for business data services, according to ex parte filings Tuesday arguing the decade-plus wait for reform has cost the company.

  • October 19, 2016

    Bodybuilding Org. Drops Antitrust Row Against Int'l League

    A new bodybuilding organization and an established international league accused of monopolizing the U.S. bodybuilding market have agreed to drop their dispute, according to a filing in Virginia federal court Tuesday.

  • October 19, 2016

    $2.6B Alaska-Virgin Merger Suit Could Speed To Dec. Trial

    A California federal judge declined to say Wednesday whether he’ll pause Alaska Airlines’ $2.6 billion acquisition of Virgin America, but did tell the parties in an antitrust suit over the tie-up to prepare for trial as soon as December if the Justice Department approves the deal.

  • October 19, 2016

    Relator Pulls State Insurance Fraud Claim Against Medtronic

    An ex-Medtronic Inc. sales rep who alleges his former employer paid doctors kickbacks won't pursue California and Illinois based private insurance fraud claims in Massachusetts federal court, dismissing them without prejudice there but leaving the option to file again somewhere else.

Expert Analysis

  • Trial Pros’ Secret To Courtroom Success

     Jamin S. Soderstrom

    Somewhat surprisingly, very few of the dozens of "trial pros" who have been interviewed by Law360 have revealed the secret to effective trial preparation that is vital to their success. But ultimately, the “secret” to effective trial preparation is not actually a secret, says Jamin Soderstrom of Soderstrom Law PC.

  • A Shift Toward Increased Antitrust Scrutiny Of Tech Cos.


    In this short video, Jonathan Kanter of Paul Weiss Rifkind Wharton & Garrison LLP discusses what we can expect in terms of U.S. antitrust enforcement against technology providers.

  • 1 Year After Yates Memo: The DOJ's Yates-Lite Approach

    Joan E. Meyer

    There have been no major signs of a Yates memo impact on large multijurisdictional cases. But the U.S. Department of Justice has issued significant settlements in the last year and presumably has the information included in those agreements to initiate individual prosecutions. So why haven’t we seen a significant increase? asks Joan Meyer of Baker & McKenzie LLP.

  • Preparing For Changes To Federal Appellate Rules

    Matthew J. Dowd

    On Dec. 1, 2016, several important amendments to the Federal Rules of Appellate Procedure take effect. The most impactful amendment is the shortening of the permissible length of appellate briefs, which will affect many appeals and will have a particularly significant impact on complex appeals such as patent cases, says Matthew Dowd of Dowd PLLC.

  • Bayer-Monsanto Won't Seed Or Weed The Patent Thicket

    Randall Brown

    While the consolidation of agribusiness has a significant effect on the global food supply, it is unlikely that the Bayer-Monsanto merger will have an anti-competitive impact from an intellectual property perspective, say Randall Brown and Catherine Reynolds of Haynes and Boone LLP.

  • Aerotec Likely To Guide 9th Circ. On Aftermarket Issues

    Shylah R. Alfonso

    A self-described “primer for aftermarket issues,” the Ninth Circuit's recent analysis and guidance in Aerotec v. Honeywell will apply to cases involving other portions of the airplane parts and services aftermarket as well as to the numerous aftermarkets in other industries, say attorneys with Perkins Coie LLP.

  • OPINION: 3rd-Party Litigation Funding Needs Transparency

    Lisa A. Rickard

    The practice of third-party litigation funding, in which funders front money to plaintiffs law firms in exchange for a cut of any settlement or money judgment, is growing increasingly popular. Currently, litigators are not required to disclose the involvement of third-party funders, but transparency will improve justice in courts, say Lisa Rickard, president of the U.S. Chamber Institute for Legal Reform, and Mark Behrens, a partne... (continued)

  • Och-Ziff: Takeaways From Landmark FCPA Case

    Jason A. Jones

    The recent Och-Ziff Capital Management enforcement action — one of the largest Foreign Corrupt Practices Act settlements in history — is notable for a number of reasons, not the least of which is that the U.S. Securities and Exchange Commission charged a sitting CEO and chief financial officer of an issuer with violating the FCPA for the first time, say attorneys with King & Spalding LLP.

  • A New Measuring Stick For Anti-Bribery Compliance Programs

    John J. Pease III

    On Saturday, the International Organization for Standardization adopted a certifiable international “anti-bribery management system” that has the potential to change how the U.S. Department of Justice, U.S. Securities and Exchange Commission, and foreign regulators evaluate and grade corporate compliance programs, say attorneys with Morgan Lewis & Bockius LLP.

  • DC Circ. Single-Director Ruling Clips CFPB’s Wings

    Eric J. Mogilnicki

    Although the D.C. Circuit's constitutional holding in PHH v. Consumer Financial Protection Bureau has dominated the headlines, the most significant aspects of the decision may be the way it prevents the CFPB from retroactively applying new interpretations of laws and bringing cases that involve alleged violations outside the relevant statutes of limitations, say Eric Mogilnicki and David Stein of Covington & Burling LLP.